AI assistant
Uni-Bio Science Group Limited — Capital/Financing Update 2013
Nov 27, 2013
49397_rns_2013-11-27_b74363e7-83cc-408e-9366-d76144b0dd7b.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
==> picture [316 x 59] intentionally omitted <==
(incorporated in the Cayman Islands with limited liability)
(stock code: 690)
GRANT OF SHARE OPTIONS
This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules ”).
The board of directors of Uni-Bio Science Group Limited (the “ Company ”) hereby announces that on 27 November 2013, share options (the “ Options ”) in respect of 469,340,000 ordinary shares of the Company (the “ Shares ”) were granted to eligible grantees under the share option scheme adopted by the Company on 22 September 2006 (the 10% general limit under the said share option scheme was refreshed pursuant to a resolution passed at the extraordinary general meeting of the Company held on 25 November 2013). The followings are the details of the Options granted:
Date of grant : 27 November 2013 Number of Options granted : 469,340,000 Exercise price of Options granted : HK$0.219 per Share
Closing price of the Shares on the : HK$0.215 per Share date of grant
-
The average closing price of the : HK$0.219 per Share Shares for the five business days immediately preceding the date of grant
-
Validity period of the Options
-
: From 27 November 2013 to 21 September 2016
-
For identification purpose only
– 1 –
Among the Share Options granted above, a total of 1,600,000 Share Options were granted to the Directors of the Company, details of which are as follows:
| Number of the | ||
|---|---|---|
| Share Options | ||
| Name of Grantees | Relationship with the Company | granted |
| Mr. Tsao Hoi Ho, Terry | Independent non-executive director | 600,000 |
| Mr. Lou Iok Kuong | Independent non-executive director | 600,000 |
| Mr. Ng Pak Kin | Independent non-executive director | 200,000 |
| Mr. Leung Wai Chung, Vincent | Independent non-executive director | 200,000 |
The grant of the Share Options to the above Directors has been approved by the Board in accordance with rule 17.04(1) of the Listing Rules.
Save as disclosed above, none of the Grantee is a Director, chief executive or Substantial Shareholder, or their respective associates (as defined in the Listing Rules).
By Order of the Board of Uni-Bio Science Group Limited Tong Kit Shing Chairman
Hong Kong, 27 November 2013
As at the date of this announcement, the executive directors of the Company are Mr. TONG Kit Shing (Chairman),Mr. LIU Guoyao and Mr. LEUNG Ka Chun; the independent non-executive directors of the Company are Mr. TSAO Hoi Ho, Terry, Mr. LOU Iok Kuong, Mr. NG Pak Kin and Mr. LEUNG Wai Chung, Vincent.
– 2 –